{"id":233,"date":"2016-12-02T12:30:40","date_gmt":"2016-12-02T11:30:40","guid":{"rendered":"http:\/\/stellbrink-partner.com\/site\/?p=233"},"modified":"2016-12-02T12:30:40","modified_gmt":"2016-12-02T11:30:40","slug":"epo-decides-no-to-poisonous-priorities","status":"publish","type":"post","link":"https:\/\/stellbrink-partner.com\/site\/2016\/12\/02\/epo-decides-no-to-poisonous-priorities\/","title":{"rendered":"EPO decides: “No” to poisonous priorities"},"content":{"rendered":"

The Enlarged Board of Appeal has recently issued its much awaited order in the G 1\/15 case relating to partial priorities of a generic claim.<\/p>\n

Shortly summarized, this relates to the following situation. A first application is filed and discloses a specific embodiment (e.g., a screw). Later, a second application is filed and its claim relates to a more generic embodiment (e.g., means of attachment).<\/p>\n

The question at issue is then whether the second application can validly claim the priority of the first application, as far as a screw is concerned \u2013 that is, whether the claim has a partial priority as far as it covers the screw. This is also relevant for the following reason: If the priority of the first application could not be validly claimed, it would destroy the novelty of the second application, as a specific embodiment (the screw) deprives the more general subject-matter (means of attachment) of novelty. This is why this scenario is also known as a \u201cpoisonous priority\u201d.<\/p>\n

The Enlarged Board of Appeal, which is the highest instance of the European Patent Office, has now ordered that the generic term can validly claim the partial priority of the more specific term previously disclosed. See the full order here<\/a>.<\/p>\n

This will be good news for patent applicants and patent practitioners!<\/p>\n","protected":false},"excerpt":{"rendered":"

The Enlarged Board of Appeal has recently issued its much awaited order in the G 1\/15 case relating to partial priorities of a generic claim. Shortly summarized, this relates to the following situation. A first application is filed and discloses a specific embodiment (e.g., a screw). Later, a… Read More<\/a><\/span><\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[19,20,14,22,21],"class_list":["post-233","post","type-post","status-publish","format-standard","hentry","category-mehr","tag-epo","tag-partial-priorities","tag-patent","tag-poisonous-divisonals","tag-poisonous-priorities"],"yoast_head":"\nEPO decides: "No" to poisonous priorities - Stellbrink & Partner Patentanw\u00e4lte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/stellbrink-partner.com\/site\/2016\/12\/02\/epo-decides-no-to-poisonous-priorities\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EPO decides: "No" to poisonous priorities - Stellbrink & Partner Patentanw\u00e4lte\" \/>\n<meta property=\"og:description\" content=\"The Enlarged Board of Appeal has recently issued its much awaited order in the G 1\/15 case relating to partial priorities of a generic claim. Shortly summarized, this relates to the following situation. A first application is filed and discloses a specific embodiment (e.g., a screw). Later, a… Read More\" \/>\n<meta property=\"og:url\" content=\"https:\/\/stellbrink-partner.com\/site\/2016\/12\/02\/epo-decides-no-to-poisonous-priorities\/\" \/>\n<meta property=\"og:site_name\" content=\"Stellbrink & Partner Patentanw\u00e4lte\" \/>\n<meta property=\"article:published_time\" content=\"2016-12-02T11:30:40+00:00\" \/>\n<meta name=\"author\" content=\"DJ\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"DJ\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"1\u00a0Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/stellbrink-partner.com\/site\/2016\/12\/02\/epo-decides-no-to-poisonous-priorities\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/stellbrink-partner.com\/site\/2016\/12\/02\/epo-decides-no-to-poisonous-priorities\/\"},\"author\":{\"name\":\"DJ\",\"@id\":\"https:\/\/stellbrink-partner.com\/site\/#\/schema\/person\/e9da2b5a5bee66bc1c6677561ea92d11\"},\"headline\":\"EPO decides: “No” to poisonous priorities\",\"datePublished\":\"2016-12-02T11:30:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/stellbrink-partner.com\/site\/2016\/12\/02\/epo-decides-no-to-poisonous-priorities\/\"},\"wordCount\":222,\"keywords\":[\"EPO\",\"Partial Priorities\",\"Patent\",\"Poisonous Divisonals\",\"Poisonous Priorities\"],\"articleSection\":[\"Mehr\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/stellbrink-partner.com\/site\/2016\/12\/02\/epo-decides-no-to-poisonous-priorities\/\",\"url\":\"https:\/\/stellbrink-partner.com\/site\/2016\/12\/02\/epo-decides-no-to-poisonous-priorities\/\",\"name\":\"EPO decides: \\\"No\\\" to poisonous priorities - Stellbrink & Partner Patentanw\u00e4lte\",\"isPartOf\":{\"@id\":\"https:\/\/stellbrink-partner.com\/site\/#website\"},\"datePublished\":\"2016-12-02T11:30:40+00:00\",\"author\":{\"@id\":\"https:\/\/stellbrink-partner.com\/site\/#\/schema\/person\/e9da2b5a5bee66bc1c6677561ea92d11\"},\"breadcrumb\":{\"@id\":\"https:\/\/stellbrink-partner.com\/site\/2016\/12\/02\/epo-decides-no-to-poisonous-priorities\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/stellbrink-partner.com\/site\/2016\/12\/02\/epo-decides-no-to-poisonous-priorities\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/stellbrink-partner.com\/site\/2016\/12\/02\/epo-decides-no-to-poisonous-priorities\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/stellbrink-partner.com\/site\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EPO decides: “No” to poisonous priorities\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/stellbrink-partner.com\/site\/#website\",\"url\":\"https:\/\/stellbrink-partner.com\/site\/\",\"name\":\"Stellbrink & Partner Patentanw\u00e4lte\",\"description\":\"Patentanw\u00e4lte mbB\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/stellbrink-partner.com\/site\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/stellbrink-partner.com\/site\/#\/schema\/person\/e9da2b5a5bee66bc1c6677561ea92d11\",\"name\":\"DJ\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\/\/stellbrink-partner.com\/site\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f2168a42ea163ca2c821f3f2f9cf8e35?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f2168a42ea163ca2c821f3f2f9cf8e35?s=96&d=mm&r=g\",\"caption\":\"DJ\"},\"url\":\"https:\/\/stellbrink-partner.com\/site\/author\/svr1610\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EPO decides: \"No\" to poisonous priorities - Stellbrink & Partner Patentanw\u00e4lte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/stellbrink-partner.com\/site\/2016\/12\/02\/epo-decides-no-to-poisonous-priorities\/","og_locale":"de_DE","og_type":"article","og_title":"EPO decides: \"No\" to poisonous priorities - Stellbrink & Partner Patentanw\u00e4lte","og_description":"The Enlarged Board of Appeal has recently issued its much awaited order in the G 1\/15 case relating to partial priorities of a generic claim. Shortly summarized, this relates to the following situation. A first application is filed and discloses a specific embodiment (e.g., a screw). Later, a… Read More","og_url":"https:\/\/stellbrink-partner.com\/site\/2016\/12\/02\/epo-decides-no-to-poisonous-priorities\/","og_site_name":"Stellbrink & Partner Patentanw\u00e4lte","article_published_time":"2016-12-02T11:30:40+00:00","author":"DJ","twitter_card":"summary_large_image","twitter_misc":{"Verfasst von":"DJ","Gesch\u00e4tzte Lesezeit":"1\u00a0Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/stellbrink-partner.com\/site\/2016\/12\/02\/epo-decides-no-to-poisonous-priorities\/#article","isPartOf":{"@id":"https:\/\/stellbrink-partner.com\/site\/2016\/12\/02\/epo-decides-no-to-poisonous-priorities\/"},"author":{"name":"DJ","@id":"https:\/\/stellbrink-partner.com\/site\/#\/schema\/person\/e9da2b5a5bee66bc1c6677561ea92d11"},"headline":"EPO decides: “No” to poisonous priorities","datePublished":"2016-12-02T11:30:40+00:00","mainEntityOfPage":{"@id":"https:\/\/stellbrink-partner.com\/site\/2016\/12\/02\/epo-decides-no-to-poisonous-priorities\/"},"wordCount":222,"keywords":["EPO","Partial Priorities","Patent","Poisonous Divisonals","Poisonous Priorities"],"articleSection":["Mehr"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/stellbrink-partner.com\/site\/2016\/12\/02\/epo-decides-no-to-poisonous-priorities\/","url":"https:\/\/stellbrink-partner.com\/site\/2016\/12\/02\/epo-decides-no-to-poisonous-priorities\/","name":"EPO decides: \"No\" to poisonous priorities - Stellbrink & Partner Patentanw\u00e4lte","isPartOf":{"@id":"https:\/\/stellbrink-partner.com\/site\/#website"},"datePublished":"2016-12-02T11:30:40+00:00","author":{"@id":"https:\/\/stellbrink-partner.com\/site\/#\/schema\/person\/e9da2b5a5bee66bc1c6677561ea92d11"},"breadcrumb":{"@id":"https:\/\/stellbrink-partner.com\/site\/2016\/12\/02\/epo-decides-no-to-poisonous-priorities\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/stellbrink-partner.com\/site\/2016\/12\/02\/epo-decides-no-to-poisonous-priorities\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/stellbrink-partner.com\/site\/2016\/12\/02\/epo-decides-no-to-poisonous-priorities\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/stellbrink-partner.com\/site\/"},{"@type":"ListItem","position":2,"name":"EPO decides: “No” to poisonous priorities"}]},{"@type":"WebSite","@id":"https:\/\/stellbrink-partner.com\/site\/#website","url":"https:\/\/stellbrink-partner.com\/site\/","name":"Stellbrink & Partner Patentanw\u00e4lte","description":"Patentanw\u00e4lte mbB","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/stellbrink-partner.com\/site\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Person","@id":"https:\/\/stellbrink-partner.com\/site\/#\/schema\/person\/e9da2b5a5bee66bc1c6677561ea92d11","name":"DJ","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/stellbrink-partner.com\/site\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f2168a42ea163ca2c821f3f2f9cf8e35?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f2168a42ea163ca2c821f3f2f9cf8e35?s=96&d=mm&r=g","caption":"DJ"},"url":"https:\/\/stellbrink-partner.com\/site\/author\/svr1610\/"}]}},"_links":{"self":[{"href":"https:\/\/stellbrink-partner.com\/site\/wp-json\/wp\/v2\/posts\/233","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stellbrink-partner.com\/site\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stellbrink-partner.com\/site\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stellbrink-partner.com\/site\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/stellbrink-partner.com\/site\/wp-json\/wp\/v2\/comments?post=233"}],"version-history":[{"count":1,"href":"https:\/\/stellbrink-partner.com\/site\/wp-json\/wp\/v2\/posts\/233\/revisions"}],"predecessor-version":[{"id":234,"href":"https:\/\/stellbrink-partner.com\/site\/wp-json\/wp\/v2\/posts\/233\/revisions\/234"}],"wp:attachment":[{"href":"https:\/\/stellbrink-partner.com\/site\/wp-json\/wp\/v2\/media?parent=233"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stellbrink-partner.com\/site\/wp-json\/wp\/v2\/categories?post=233"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stellbrink-partner.com\/site\/wp-json\/wp\/v2\/tags?post=233"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}